Activation of ERK1/2 pathway mediates oxidant-induced decreases in mitochondrial function in renal cells
- 1 October 2006
- journal article
- research article
- Published by American Physiological Society in American Journal of Physiology-Renal Physiology
- Vol. 291 (4) , F840-F855
- https://doi.org/10.1152/ajprenal.00219.2005
Abstract
Previously, we showed that oxidant exposure in renal proximal tubular cells (RPTC) induces mitochondrial dysfunction mediated by PKC-ε. This study examined the role of ERK1/2 in mitochondrial dysfunction induced by oxidant injury and whether PKC-ε mediates its effects on mitochondrial function through the Raf-MEK1/2-ERK1/2 pathway. Sublethal injury produced by tert-butylhydroperoxide (TBHP) resulted in three- to fivefold increase in phosphorylation of ERK1/2 and p38 but not JNK. This was followed by decreases in basal and uncoupled respirations (41%), state 3 respiration and ATP production coupled to complex I (46%), and complex I activity (42%). Oxidant exposure decreased aconitase activity 30% but not pyruvate, α-ketoglutarate, and malate dehydrogenase activities. Inhibition of ERK1/2 restored basal and state 3 respirations, ΔΨm, ATP production, and complex I activity but not aconitase activity. In contrast, activation of ERK1/2 by expression of constitutively active MEK1 suppressed basal, uncoupled, and state 3 respirations in noninjured RPTC to the levels observed in TBHP-injured RPTC. MEK1/2 inhibition did not change Akt or p38 phosphorylation, demonstrating that the protective effect of MEK1/2 inhibitor was not due to activation of Akt or inhibition of p38 pathway. Inhibition of PKC-ε did not block TBHP-induced ERK1/2 phosphorylation in whole RPTC or in mitochondria. We conclude that 1) oxidant-induced activation of ERK1/2 but not p38 or JNK reduces mitochondrial respiration and ATP production by decreasing complex I activity and substrate oxidation through complex I, 2) citric acid cycle dehydrogenases are not under control of the ERK1/2 pathway in oxidant-injured RPTC, 3) the protective effects of ERK1/2 inhibition are not due to activation of Akt, and 4) ERK1/2 and PKC-ε mediate oxidant-induced mitochondrial dysfunction through independent pathways.Keywords
This publication has 52 references indexed in Scilit:
- Protein kinase C-α inhibits the repair of oxidative phosphorylation afterS-(1,2-dichlorovinyl)-l-cysteine injury in renal cellsAmerican Journal of Physiology-Renal Physiology, 2004
- Exogenous nitric oxide generates ROS and induces cardioprotection: involvement of PKG, mitochondrial KATP channels, and ERKAmerican Journal of Physiology-Heart and Circulatory Physiology, 2004
- Inhibition of Ligand-independent ERK1/2 Activity in Kidney Proximal Tubular Cells Deprived of Soluble Survival Factors Up-regulates Akt and Prevents ApoptosisJournal of Biological Chemistry, 2004
- Inhibition of caspase-9 through phosphorylation at Thr 125 by ERK MAPKNature Cell Biology, 2003
- Activation of the ERK pathway precedes tubular proliferation in the obstructed rat kidneyKidney International, 2003
- Significant Neuroprotection against Ischemic Brain Injury by Inhibition of the MEK1 Protein Kinase in Mice: Exploration of Potential Mechanism Associated with ApoptosisThe Journal of Pharmacology and Experimental Therapeutics, 2003
- Oxidant mechanisms in toxic acute renal failureAmerican Journal of Kidney Diseases, 1997
- Mitochondrial dysfunction is an early event in ochratoxin a but not oosporein toxicity to rat renal proximal tubulesToxicology and Applied Pharmacology, 1991
- Nephrotoxicity of cisplatin, carboplatin and transplatinArchives of Toxicology, 1990
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970